**Chinese Library Classification No.** R453; R364; R741

Introduction {#sec1-1}
============

Stroke is a major cause of death, adult chronic disability, and dementia. Ischemic stroke accounts for approximately 80% of stroke cases, which may be caused by hypertension, dyslipidemia, lifestyle, and/or genetic factors (Zhao et al., 2017). Many clinical methods, such as anticoagulation and thrombolysis treatment, have been used to treat cerebrovascular diseases; however, vascular recanalization could aggravate brain tissue damage and cause delayed nerve cell death, thus eliciting cerebral ischemia/reperfusion (I/R) injury (Certo et al., 2015; Sadana et al., 2015; Hartig et al., 2017). Despite widespread research, there is no effective treatment for cerebral I/R injury so far. Therefore, understanding its molecular mechanisms may provide novel insights into the development of effective treatments for cerebral I/R injury.

The Notch pathway, an evolutionarily conserved signaling system, has been recognized as an important adaptive signaling pathway that participates in various biological processes, such as neuronal proliferation, differentiation and apoptosis (Nemir and Pedrazzini, 2008; Wickremasinghe et al., 2011). Previous studies have shown that the classical biological effects of Notch signaling are mediated through interactions between Notch receptors and their ligands to release the Notch intracellular domain, which then forms a transcription-activating complex to regulate Notch-dependent gene expression, such as Hes1 and Hes5 (Mahler et al., 2010; Osathanon et al., 2013; Zhang et al., 2015). N-\[N-(3,5-difluorohenacetyl)-l-alanyl\]-S-phenylglycine tert-butyl ester (DAPT), a common γ-secretase inhibitor, can effectively inhibit release of the Notch intracellular domain from the Notch receptor during the enzymatic digestion process (Lee et al., 2017).

Inflammatory responses and apoptosis are crucial mechanisms involved in cerebral I/R injury (Broughton et al., 2009; Siniscalchi et al., 2014). Recently, several studies found a significant reduction of blood flow in the ischemic core, whereby programmed cell apoptosis and inflammatory responses occurred in the ischemic penumbra (Xu and Zhang, 2011; Ghosh et al., 2012; Kalogeris et al., 2012; Hu et al., 2017). Moreover, DAPT could protect against renal I/R injury by suppressing inflammation and apoptosis (Huang et al., 2011). However, no direct evidence has indicated involvement of the Notch pathway in the protective effects of glial fibrillary acidic protein (GFAP) and/or Hes1 and Hes5 protein expression on cerebral I/R injury. Therefore, this study aimed to investigate the role of DAPT and its putative mechanism in mice with cerebral I/R injury to provide a new strategy for the prevention and treatment of cerebrovascular disease.

Materials and Methods {#sec1-2}
=====================

Animals {#sec2-1}
-------

In total, 204 healthy male Kunming mice, aged 3--4 months and weighing 30--35 g, were purchased from the Experimental Animal Center of Guizhou Medical University, China \[License No. SYXK(Qian) 2012-0004\]. All mice were housed at 50--70% humidity and 22--24°C under a 12-hour light/dark cycle. All experiments were conducted in accordance with the guidelines of the Ministry of Health of China for Animal Care and Use. The study protocol was approved by the Experimental Animal Research Committee of Guizhou Medical University, China. Food and water were freely available during all phases of the experiment. Mice were randomly divided into a sham group (*n* = 68), I/R group (I/R only) (*n* = 68) and DAPT group (I/R + DAPT treatment) (*n* = 68). Each group was divided into four subgroups: 1, 3, 7 and 14 days.

Mouse models of focal cerebral ischemia/reperfusion injury {#sec2-2}
----------------------------------------------------------

Mice were acclimated to the facility for one week prior to surgery. I/R mouse models were established as previously described by Longa et al. (1989). In brief, mice were intraperitoneally anesthetized with 5 mL/kg of 10% (w/v) chloral hydrate and secured on the operating table. Through a midline cervical incision, the bilateral common carotid arteries were exposed and gently separated from the carotid sheath and vagus nerve. The right common carotid artery, internal carotid artery, and external carotid artery were exposed and isolated. A microvascular clamp (Roboz, Berlin, Germany) was used to temporarily clip the internal carotid artery. A small cut was made at the common carotid artery from the bifurcation 3--4 mm. A 2.0-cm nylon suture (diameter 0.16 ± 0.02 mm) with its tip rounded by heating into the internal carotid artery was made until it closed the origin of the middle cerebral artery. Sham group mice underwent identical surgery, but did not have the suture inserted. The body temperature of mice was maintained at 37°C through all surgical and postoperative procedures until mice regained consciousness. After recovery from anesthesia, all mice were kept in the animal quarters with free access to food and water.

Drug intervention {#sec2-3}
-----------------

DAPT solution (20 mg/mL; MCE Co., Monmouth Junction, NJ) was prepared by dissolving DAPT powder in dimethyl sulfoxide. In the DAPT group, DAPT solution (5 mL/kg) was injected intraperitoneally 3 hours before middle cerebral artery occlusion. Mice in the other two groups were injected with 5 mL/kg dimethyl sulfoxide solution (Wang et al., 2015).

Neurobehavioral assessment {#sec2-4}
--------------------------

According to the Longa scoring method (1989), neurobehavioral deficits were evaluated by an observer blinded to the identity of groups at 2 hours before sampling and rated on a scale of 0--4. Score 0: No obvious behavioral deficit. Score 1: Left forelimb showed a mild obvious neurobehavioral deficit and failed to straighten. Score 2: Mice showed a trend of circling to the left. Score 3: Mice spontaneously walked in a left circle. Score 4: Mice could not walk spontaneously and lost consciousness. Mice scored 1--3 were included in this study, but mice not showing behavioral deficits at the four time points were excluded from the study.

Preparation of paraffin sections {#sec2-5}
--------------------------------

In each subgroup, mice (*n* = 5) were anesthetized with 5% (8 mL/kg) chloral hydrate and perfused with physiological saline *via* an aortic root catheter until the liver appeared to be white, followed by 4% paraformaldehyde solution that had been cooled to 4°C. Brains were removed and post-fixed in 4% paraformaldehyde solution overnight at 4°C. After dehydration and embedding in paraffin, 7-μm coronal sections of brain were used for immunofluorescence, Nissl, and TdT-mediated dUTP-biotin nick-end labeling (TUNEL) staining.

Nissl and TUNEL staining of the right prefrontal cortex {#sec2-6}
-------------------------------------------------------

Paraffin sections were stained with Nissl (Solarbio Biotechnology, Beijing, China) and imaged using a light microscope (Olympus, Tokyo, Japan) at 400× magnification. Apoptotic cells in brain sections were identified by the TUNEL staining kit (KeyGen BioTech, Nanjing, China) as previously described (Wicha et al., 2017). Paraffin sections were deparaffinized, treated with 3% hydrogen peroxide and TdT enzyme, and incubated with digoxigenin-conjugated antibodies. Sections were photographed using a light microscope (Olympus). Nissl- and TUNEL-positive cells were counted using Image-Pro Plus 6.0 software (Media Cybernetics, Silver Spring, MD, USA).

Immunofluorescence staining {#sec2-7}
---------------------------

To detect Notch1- and GFAP-positive cells in the right cerebral cortex of the ischemic hemisphere, brain sections were incubated for 30 minutes in 2.0 M HCl to denature DNA, and the reaction was neutralized in 0.1 M boric acid for 10 minutes. Thereafter, brain sections were rinsed in phosphate-buffered saline (PBS) containing 0.3% Triton for 30 minutes, preincubated in 10% normal goat serum for 2 hours at room temperature, and incubated with polyclonal rabbit anti-Notch1 (1:150; Biosynthesis Biotechnology, Beijing, China) and monoclonal rabbit anti-GFAP (astrocyte marker) antibody (1:200; Boster Biotechnology, Wuhan, China) at 4°C overnight, and then incubated with Cy3-conjugated affinity-purified goat anti-rabbit IgG (1:100; Sigma, St. Louis, MO, USA) in a humidified chamber for 1 hour at 37°C. Anti-Notch1 and anti-GFAP were used as cell-type specific markers in each brain section. Numbers of Notch1- and GFAP-positive cells were counted by laser-scanning confocal microscopy (Olympus).

Western blot assay {#sec2-8}
------------------

Mice (*n* = 5) from each subgroup were anesthetized with 5% (8 mL/kg) chloral hydrate, and perfused with physiological saline rapidly *via* an aortic root catheter. Brains were removed quickly and frozen at --80°C. Brain tissue from the right cerebral cortex was homogenized by adding protein extraction buffer at a 1:5 volume to tissue weight in a glass homogenizer. Sample protein concentrations were determined using a bicinchoninic acid assay kit (Beyotime Biotechnology, Shanghai, China). Hes1 and Hes5 proteins were loaded onto 5% stacking/10% separating sodium dodecyl sulphate-polyacrylamide gels (Solarbio Biotechnology, Beijing, China) for electrophoresis, and then transferred onto polyvinylidene difluoride membranes (Millipore, Billerica, MA, USA). After blocking with 5% skimmed milk powder, membranes were incubated with rabbit polyclonal anti-Hes1, anti-Hes5 (1:200; Biosynthesis Biotechnology), and rabbit polyclonal anti-β-actin (1:4000; ImmunoWay, Plano, TX, USA) overnight at 4°C. After washing with PBS for approximately 15 minutes, membranes were incubated with horseradish peroxidase-conjugated secondary goat-anti-rabbit antibody (1:6000; Proteintech, Chicago, IL, USA) for 2 hours at room temperature. Proteins were visualized using a sensitivity-enhanced chemiluminescence solution (Millipore). Finally, the intensity of blots was quantified using a Multi-Functional Imaging System (Bio-Rad, Hercules, CA, USA). Relative amounts of proteins were calculated as the ratio of Hes1 or Hes5 to β-actin.

Transmission electron microscopy {#sec2-9}
--------------------------------

Transmission electron microscopy was used to evaluate neuronal ultrastructural changes within the right prefrontal cortex in each subgroup (*n* = 2). Brain tissues from the right prefrontal cortex were cut into 1 mm^3^ sections and immediately fixed in 2.5% glutaraldehyde solution at 4°C overnight. After washing with 0.1 M PBS (pH 7.4), sections were fixed with 1% osmic acid (Pelco, CA, USA) for approximately 1 hour. Following dehydration in ethyl alcohol, brain tissues were embedded in Epon-Araldite resin (EMS, San Francisco, CA, USA), cut into ultrathin sections (approximately 50 nm), examined with transmission electron microscopy (Hitachi-7500, Tokyo, Japan), and imaged.

Enzyme-linked immunosorbent assay {#sec2-10}
---------------------------------

Remnant mice from each group were sacrificed at different time points. The right prefrontal cortex was separated and cleared by cold saline to prepare 10% fresh brain tissue homogenates. According to the manufacturer's protocol (Neo Bioscience, Beijing, China), amounts of interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) released in the right prefrontal cortex were measured by enzyme-linked immunosorbent assay.

Statistical analysis {#sec2-11}
--------------------

Data are expressed as the mean ± standard deviation (SD). All data were analyzed using SPSS 19.0 software (SPSS, Chicago, IL, USA) by an observer blinded to experimental groupings. A one-way analysis of variance followed by Student-Newman-Keuls test was used to assess statistical significance. A value of *P* \< 0.05 was considered statistically significant.

Results {#sec1-3}
=======

DAPT improves neurobehavioral deficits of cerebral I/R mice {#sec2-12}
-----------------------------------------------------------

The results of neurobehavioral scores are shown in **[Figure 1](#F1){ref-type="fig"}**. In the sham group, there was no obvious neurologic dysfunction in mice. Cerebral I/R mice showed more severe neurological function injury compared with the sham group (*P* \< 0.01). After DAPT treatment, neurobehavioral deficits were significantly improved (*P* \< 0.05).

![Neurobehavioral scores of cerebral I/R mice following DAPT treatment.\
Zea-Longa's neurobehavioral score was obtained for each group. Higher scores represent more severe neurological function deficits. Data are shown as the mean ± SD (*n* = 20 per subgroup; one-way analysis of variance followed by Student-Newman-Keuls test). ^\*^*P* \< 0.01, *vs*. sham group; \#*P* \< 0.05, *vs*. I/R group. I/R: Ischemia/reperfusion; DAPT: N-\[N-(3,5-difluorohenacetyl)-l-alanyl\]-S-phenylglycine tert-butyl ester; d: day(s).](NRR-14-452-g002){#F1}

DAPT alleviates pathological injury of neurons {#sec2-13}
----------------------------------------------

The sham group showed normal neural structures with clear cell outlines, central nuclei, and abundant Nissl bodies in the cytoplasm (**Figure [2A](#F2){ref-type="fig"}** and **[B](#F2){ref-type="fig"}**). In contrast, neural cells of the I/R group showed obvious injury, with shrunken cell bodies, pyknosis, and breaking and dissolution of nuclei. In the 1-day I/R subgroup, neurons presented slight injury. In the 3-day I/R subgroup, neurons were disorganized and nuclear pyknosis occurred. Neurons exhibited the worst damage (Nissl bodies dissolved or disappeared) in the 7-day I/R subgroup. Cellular kernel pyknosis displayed as triangular-shaped cells. The clearance surrounding between neural cells was widened (**[Figure 2D](#F2){ref-type="fig"}**). Numbers of neurons in the 14-day I/R subgroup increased and the damage was slightly relieved compared with the 7-day I/R subgroup. However, compared with the I/R subgroup, DAPT could alleviate neuronal damage in the DAPT group at different time points (**Figure [2I](#F2){ref-type="fig"}** and **[K](#F2){ref-type="fig"}**).

![Neurons of the right prefrontal cortex in cerebral I/R mice following DAPT treatment as assessed by optical microscopy.\
(A) Right cerebral cortex area of mice: box indicates right prefrontal cortex. Scale bar: 1 mm. (B--J) Magnified figures of the box from A (Scale bars: 10 μm). (B) Sham group: Neurons were arranged normally, and Nissl bodies in the cytoplasm were abundant. (C) 1-day I/R subgroup; (D) 3-day I/R subgroup; (E) 7-day I/R subgroup; (F) 14-day I/R subgroup; (G) 1-day DAPT subgroup; (H) 3-day DAPT subgroup; (I) 7-day DAPT subgroup; (J) 14-day DAPT subgroup; (K) Quantitation of Nissl-positive cells at 400× magnification. Data are shown as the mean ± SD (*n* = 5 per subgroup; one-way analysis of variance followed by Student-Newman-Keuls test). ^\*^*P* \< 0.01, *vs*. sham group; \#*P* \< 0.05, *vs*. I/R group. I/R: Ischemia/reperfusion; DAPT: N-\[N-(3,5-difluorohenacetyl)-l-alanyl\]-S-phenylglycine tert-butyl ester; d: day(s).](NRR-14-452-g003){#F2}

DAPT decreases cell apoptosis {#sec2-14}
-----------------------------

In the sham group, no obvious TUNEL-positive cells were observed in the right prefrontal cortex of brain tissues (**[Figure 3](#F3){ref-type="fig"}**). Compared with the sham group, a few TUNEL-positive cells appeared in cerebral I/R mice (*P* \< 0.01; **[Figure 3J](#F3){ref-type="fig"}**). Quantitative analyses (**[Figure 3J](#F3){ref-type="fig"}**) demonstrated significantly less TUNEL-positive neurons in the DAPT group than in the I/R group (*P* \< 0.05).

![Cell apoptosis in the right prefrontal cortex area in cerebral I/R mice following DAPT treatment, as assessed by fluorescence microscopy.\
(A--I) Representative images of TUNEL staining at 400× magnification. Apoptotic cells were labeled green, while nuclei were labeled blue with DAPI in A--I. Scale bars: 10 μm. (A) Sham group: No obvious apoptotic cells. (B--E) 1-day, 3-day, 7-day, and 14-day I/R subgroups, respectively: numbers of apoptotic cells was increased compared with the sham group (arrows). (F--I) 1-day, 3-day, 7-day, and 14-day DAPT subgroups, respectively: numbers of apoptotic cells was reduced compared with the I/R group (arrows). (J) Number of apoptotic cells (number/view). Data are expressed as the mean ± SD (*n* = 5 per group at each time point; one-way analysis of variance followed by Student-Newman-Keuls test). ^\*^*P* \< 0.01, *vs*. sham group; \#*P* \< 0.05, *vs*. I/R group. I/R: Ischemia/reperfusion; TUNEL: TdT-mediated dUTP-biotin nick-end labeling; DAPT: N-\[N-(3,5-difluorohenacetyl)-l-alanyl\]-S-phenylglycine tert-butyl ester; DAPI: 4′,6-diamidino-2-phenylindole; d: day(s).](NRR-14-452-g004){#F3}

DAPT decreases GFAP-positive cells

In the sham group, a few GFAP-positive cells appeared (**[Figure 4A](#F4){ref-type="fig"}**). In the 1-day I/R subgroup, GFAP-positive cells began to increase compared with the sham group (**[Figure 4B](#F4){ref-type="fig"}**). In the 3-day I/R subgroup, GFAP-positive cells exhibited star shapes and were also significantly enhanced compared with the sham group, but GFAP-positive cells were significantly decreased in the DAPT group (*P* \< 0.01) (**Figure [4C](#F4){ref-type="fig"}** and **[J](#F4){ref-type="fig"}**). In addition, among the four subgroups of the I/R group, GFAP-positive cells reached a peak at 7 days, and showed thickened and shortened processes (**[Figure 4D](#F4){ref-type="fig"}**). Compared with the 14-day I/R subgroup, numbers of GFAP-positive cells decreased and cell staining became shallower in the DAPT group (*P* \< 0.01; **Figure [4E](#F4){ref-type="fig"}** and **[J](#F4){ref-type="fig"}**). These results indicated that cerebral I/R injury increased the expression of GFAP-positive cells and induced activation of gliosis. However, DAPT treatment evidently suppressed the activation of astrocytes with small cell bodies and slender processes at four time points (**Figure [4F](#F4){ref-type="fig"}--[J](#F4){ref-type="fig"}**).

![Immunofluorescence microscopy of GFAP in the right prefrontal cortex of cerebral I/R mice following DAPT treatment.\
(A--I) GFAP-immunoreactive cells (arrows) were examined in the prefrontal cortex by immunofluorescence labeling at 400× magnification. GFAP-positive cells were labeled red, and the labeling was mainly localized to the cytoplasm. Nuclei were labeled blue with DAPI in A--I. Scale bars: 10 μm. (A) Sham group: A few GFAP-immunoreactive cells. (B--E) 1-day, 3-day, 7-day, and 14-day I/R subgroups, respectively: More GFAP-positive cells were visible compared with the sham group (arrows). (F--I) 1 -day, 3 -day, 7 -day, and 14 -day DAPT subgroups, respectively: fewer GFAP-positive cells were observed compared with the I/R group (arrows). (J) Quantitation analysis of GFAP-immunoreactive cells. Data are expressed as the mean ± SD (*n* = 5 per subgroup; one-way analysis of variance followed by Student-Newman-Keuls test). ^\*^*P* \< 0.01, *vs*. sham group; \#*P* \< 0.05, *vs*. I/R group. I/R: Ischemia/reperfusion; DAPT: N-\[N-(3,5-difluorohenacetyl)-l-alanyl\]-S-phenylglycine tert-butyl ester; GFAP: glial fibrillary acidic protein; DAPI: 4′,6-diamidino-2-phenylindole; d: day(s).](NRR-14-452-g005){#F4}

DAPT reduces Notch1-positive cells {#sec2-15}
----------------------------------

Notch1-positive signal was concentrated in the cytoplasm, while nuclei were dyed blue by 4′,6-diamidino-2-phenylindole (DAPI). As shown in **[Figure 5A](#F5){ref-type="fig"}**, a few Notch1-positive cells were observed in the sham group. Compared with the sham group, more Notch1-positive cells appeared in the cerebral cortex of the I/R group at each time point (*P* \< 0.01; **Figure [5B](#F5){ref-type="fig"}--[J](#F5){ref-type="fig"}**). After DAPT treatment, Notch1-positive cells were decreased compared with the I/R group at different time points (*P* \< 0.05; **Figure [5F](#F5){ref-type="fig"}--[J](#F5){ref-type="fig"}**). Among the four DAPT treatment subgroups, numbers of Notch1-positive cells remained highest at 7 days.

![Immunofluorescence microscopy of Notch1 in the prefrontal cortex area of cerebral I/R mice following DAPT treatment.\
(A--I) Notch1-immunoreactive cells were examined in the prefrontal cortex by immunofluorescence labeling at 400× magnification. Scale bars: 10 μm. (A) Sham group: A few Notch1-immunoreactive cells. (B--E) 1-day, 3-day, 7-day, and 14-day I/R subgroups, respectively: more Notch1-positive cells were detectable compared with the sham group (arrows). (F--I) 1-day, 3-day, 7-day, and 14-day DAPT subgroups, respectively: fewer Notch1-positive cells were apparent compared with the I/R group (arrows). (J) Quantification of Notch1-positive cells. Data are expressed as the mean ± SD (*n* = 5 per group at each time point; one-way analysis of variance followed by Student-Newman-Keuls test). ^\*^*P* \< 0.01, *vs*. sham group; \#*P* \< 0.05, *vs*. I/R group. I/R: Ischemia/reperfusion; DAPT: N-\[N-(3,5-difluorohenacetyl)-l-alanyl\]-S-phenylglycine tert-butyl ester; d: day(s).](NRR-14-452-g006){#F5}

DAPT inhibits expression of Hes1 and Hes5 {#sec2-16}
-----------------------------------------

Hes1 and Hes5 protein expression levels in the right prefrontal cortex were measured by western blot assay, as shown in **[Figure 6](#F6){ref-type="fig"}**. Compared with the sham group, protein expression of Hes1 and Hes5 was increased in the I/R group (*P* \< 0.01). However, the two proteins were remarkably decreased in the DAPT group compared with the I/R group at different time points (*P* \< 0.05).

![Western blot assay for Hes1 (A) and Hes5 (B) protein expression in the right prefrontal cortex of cerebral I/R mice following DAPT treatment.\
Expression was calculated as the ratio of optical density of the target protein to that of β-actin. Data are expressed as the mean ± SD (*n* = 5 per group at each time point; one-way analysis of variance followed by Student-Newman-Keuls test). ^\*^*P* \< 0.01, *vs*. sham group; \#*P* \< 0.05, *vs*. I/R group. I/R: Ischemia/reperfusion; DAPT: N-\[N-(3,5-difluorohenacetyl)-l-alanyl\]-S-phenylglycine tert-butyl ester; d: day(s).](NRR-14-452-g007){#F6}

DAPT alleviates ultrastructural damage of neurons {#sec2-17}
-------------------------------------------------

In the sham group, neurons exhibited abundant organelles in the cytoplasm (**[Figure 7A](#F7){ref-type="fig"}**). However, neurons in the prefrontal cortex of the I/R group showed varying degrees of damage at different time points (**Figure [7B](#F7){ref-type="fig"}--[E](#F7){ref-type="fig"}**). In the 1-day I/R subgroup, organelles were disordered, intracellular spaces became large, and the mitochondria swelled slightly (**[Figure 7B](#F7){ref-type="fig"}**). In the 3-day I/R subgroup, nuclei became pyknotic and mitochondria were markedly swelled (**[Figure 7C](#F7){ref-type="fig"}**). In the 7-day I/R subgroup, neuronal ultrastructural damage was most severe with incomplete nuclear envelopes and dissolved organelles (**[Figure 7D](#F7){ref-type="fig"}**). In the 14-day I/R subgroup, the cristae of some mitochondria were fractured and the number of organelles was increased compared with the 7-day subgroup (**[Figure 7E](#F7){ref-type="fig"}**). Results shown in **Figure [7F](#F7){ref-type="fig"}--[I](#F7){ref-type="fig"}**) revealed that DAPT treatment alleviated neuronal ultrastructural damage in mice after middle cerebral artery occlusion.

![Ultrastructure of neurons of the right prefrontal cortex in cerebral I/R mice following DAPT treatment under a transmission electron microscope.\
(A) Sham group: Neurons exhibited abundant organelles; (B) 1-day I/R subgroup: organelles were disordered and mitochondria swelled slightly (arrow); (C) 3-day I/R subgroup: nucleus exhibited pyknosis (arrow); (D) 7-day I/R subgroup: neuron exhibited incomplete nuclear envelope (arrow) and dissolved organelles (star); (E) 14-day I/R subgroup: cristae of some mitochondria were fractured (arrow); (F) 1-day DAPT subgroup; (G) 3-day DAPT subgroup; (H) 7-day DAPT subgroup; (I) 14-day DAPT subgroup. Scale bars: 1.0 μm. I/R: Ischemia/reperfusion; DAPT: N-\[N-(3,5-difluorohenacetyl)-l-alanyl\]-S-phenylglycine tert-butyl ester.](NRR-14-452-g008){#F7}

DAPT inhibits production of IL-6 and TNF-α {#sec2-18}
------------------------------------------

As shown in **[Figure 8](#F8){ref-type="fig"}**, compared with the sham group, IL-6 and TNF-α contents were significantly increased in each I/R subgroup (*P* \< 0.01). Indeed, contents of IL-6 and TNF-α in the I/R group became gradually elevated within the first 7 days and decreased from 7 to 14 days. However, IL-6 and TNF-α contents were significantly inhibited following DAPT treatment (*P* \< 0.05).

![Contents of TNF-α (A) and IL-6 (B) in the prefrontal cortex in cerebral I/R mice following DAPT treatment (enzyme linked immunosorbent assay).\
Data are presented as the mean ± SD (*n* = 5; one-way analysis of variance followed by Student-Newman-Keuls test). ^\*^*P* \< 0.01, *vs*. sham group; \#*P* \< 0.05, *vs*. I/R group. d: Day(s).](NRR-14-452-g009){#F8}

Discussion {#sec1-4}
==========

Stroke is a common cerebrovascular disorder in the aging population and constitutes the second highest principle cause of mortality (Guan et al., 2017). Ischemic stroke involves a complex pathophysiological process, appearing as calcium overload, inflammatory response, oxidative stress, and brain edema (Lee et al., 2017; Tamaki et al., 2017). Despite use of effective endovascular therapy, clinical outcomes after acute cerebral ischemic stroke remain poor (Goyal et al., 2016). As the result of severe neurological complications caused by stroke, neuroprotection in this disorder has recently become an increasingly hot topic (Zhu et al., 2012). Studies have found that the infarct area is formed by long-term ischemia, which is first focused within the ischemic center and then involves surrounding tissue, leading to an ischemic penumbra (Huang et al., 2015; Zhu et al., 2017). Restoring the perfusion of ischemic penumbra is a common clinical treatment to maintain the structural and functional integrity of neurons by inhibiting the inflammatory response (Heiss et al., 1997; Song and Yu, 2014; Liu et al., 2017).

Many studies have shown that middle cerebral artery infarction has become the main cause of ischemia in the clinic (Wijdicks et al., 2014; Chen et al., 2018). The focal cerebral ischemia model of middle cerebral artery occlusion could simulate pathological processes of ischemic cerebrovascular disease and cause mice to show symptoms similar to humans. Previous studies demonstrated a strong association between the hippocampus and prefrontal cortex and age-related cognitive decline (Paulesu et al., 1993; Levy and Goldman-Rakic, 1999). Ischemic stroke is a serious disease and threat to the cognitive abilities of people. Thus, in our present study, the right prefrontal cortex was chosen to investigate the function of neural cells.

Nissl staining is a commonly used histological method to access morphological changes of cells (Shen et al., 2014). From the results of our light microscopy and transmission electron microscopy, neural structure was normal in the sham group, with abundant organelles exhibiting clear structures. In the I/R group, the distribution and arrangement of neural cells was irregular and mitochondria presented swelling, vacuolization, and even dissolution. Apoptosis is one of the major pathogenic mechanisms underlying cerebral I/R injury (Broughton et al., 2009). Blocking neuronal apoptosis could prevent the loss of neuronal cells, minimize brain injury induced by I/R damage, and slow the onset of cerebral ischemia and necrosis (Xie et al., 2011). In the present study, I/R surgery induced increases of TUNEL-positive cells in the right prefrontal cortex. Consistent with previous studies, cerebral I/R injury could cause severe brain damage, increased apoptosis, and destroy normal structure (Deng et al., 2015; Tang et al., 2017).

Proinflammatory cytokines, such as TNF-α, IL-6 and IL-1α, have emerged as significant contributors to myocardial and cerebrovascular dysfunction (Sun et al., 2012; Kraft et al., 2017). Among several inflammatory factors, TNF-α appears to be the major pro-inflammatory cytokine with multiple mechanisms that promote inflammatory reactions (Di Paola et al., 2013). IL-6, which is produced by monocytes, macrophages and endothelial cells, is a multi-functional single chain glycoprotein cytokine with broad biological activity (Aloisi et al., 1992; Choi et al., 2017). It exhibits a rapid increase during the early stage of cerebral I/R injury, along with TNF-α and IL-1β (Frangogiannis, 2007; Wong and Crack, 2008). In this study, IL-6 and TNF-α expression in the I/R group increased significantly, in line with the results of previous studies (Baskaya et al., 2000; Shichita et al., 2012; Sanderson et al., 2013). Furthermore, when cerebral I/R injury occurred, release of IL-1β, TNF-α, IL-6 and other inflammatory factors increased the inflammation reaction, leading to irreversible neuronal damage and even apoptosis or necrosis (Siniscalchi et al., 2014).

The Notch pathway is known to regulate homeostasis and development in diverse organs, such as lung (Xu et al., 2012), liver (Kobayashi et al., 2002; Zhang et al., 2017), kidney (Barak et al., 2012) and heart (Yu et al., 2015; Luxan et al., 2016). Moreover, the Notch pathway plays a vital role in immune homeostasis, which exploits the ability to mediate intercellular communication (Nistri et al., 2017). In mammalian cells, four distinct Notch receptors (Notch1--4) and five Notch ligands have been identified (Guruharsha et al., 2012; Zhang et al., 2015; Lu et al., 2018). DAPT, a γ-secretase inhibitor, is regarded as a Notch signaling pathway inhibitor (Cao et al., 2015). In recent years, DAPT has been widely used in the study of Alzheimer's disease, atherosclerosis, and neuroblastoma (Espinoza and Miele, 2013; Qin et al., 2016). DAPT could inhibit IL-6 secretion and restrain the activation of inflammatory responses during rheumatoid arthritis (Jiao et al., 2012). Similarly, Arumugam et al. (2006) reported that DAPT could reduce neuronal damage in the focal ischemic stroke model by restraining activation of microglial cells.

Hes1 and Hes5 are important downstream target genes in the Notch signaling pathway. Indeed, expression of Hes1 and Hes5 correlates with expression of Notch1, an important component of Notch signaling. Expression levels of Notch1, Hes1, and Hes5 respond well to regulation of the Notch signaling pathway (Yoon and Gaiano, 2005; Du et al., 2013). In our study, we demonstrated that DAPT was an effective inhibitor that could markedly depress expression of Notch1, Hes1, and Hes5. By Nissl staining and transmission electron microscopy, DAPT treatment could increase the number of intact neurons, and extenuate cellular edema and mitochondrial swelling. In the DAPT group, numbers of apoptotic cells and contents of IL-6 and TNF-α were obviously reduced. Accordingly, DAPT may have a positive effect on protecting brain tissue by inhibiting the inflammatory response and decreasing apoptosis.

Astrocytes are the most abundant glial cells in the brain and GFAP is considered one of the major marker proteins in mature astrocytes (Gomes et al., 1999; Middeldorp and Hol, 2011). In addition, astrocytes play a vital role in providing general structural, metabolic, and trophic support to neurons in brain tissue (Kamphuis et al., 2012). It was found that when stroke occurred, astrocytes proliferated and became activated; that is, the cell soma enlarged and processes became shortened and thickened (Hol and Pekny, 2015; Minhas et al., 2017). Astrocytes could promote the recovery of nerve function by isolating the infarct, reconstructing the blood-brain barrier, and repairing damaged neurons (Kimelberg and Nedergaard, 2010; Sofroniew and Vinters, 2010). In addition, GFAP expression was suppressed by DAPT treatment in neonatal rats following hypoxic-ischemic brain injury (Xu and Zhang, 2011). Hence, increasing evidence suggests an important role of astrocytes in the nervous system. Our results showed that compared with the I/R group, expression of GFAP decreased after DAPT treatment. DAPT could inhibit gliosis and further improve cerebral ischemia.

In conclusion, DAPT ameliorates neuronal structural damage of the right prefrontal cortex and improves neural function. DAPT may activate mechanisms of anti-inflammation and anti-apoptosis by inhibiting the expression of GFAP. Our findings offer further theoretical evidence for DAPT as a potential therapeutic drug for cerebral I/R injury. However, the effects of DAPT on other mechanisms of cerebral I/R injury, such as reactive oxygen species and leukocyte infiltration, still require further investigation in our future studies.
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